[1]
M. Zaniuk, M. Kozłowska, A. Gorecka, M. Zawiślak, and P. Zimnicki, “Ocrelizumab as a breakthrogh in multiple sclerosis treatment”, J Educ Health Sport, vol. 11, no. 5, pp. 50–56, May 2021.